The European Commission has granted authorisations for:

Uses of 4-(1,1,3,3-Tetramethylbutyl)phenol, ethoxylated (4-tert-OPnEO):

• three uses applied for by Idexx Montpellier SAS (4 January 2033);
• one use applied for by Idexx B.V. (4 January 2033); and
• one use applied for by Instrumentation Laboratory SpA (4 January 2033).

Uses of 4-Nonylphenol, branched and linear, ethoxylated (4-NPnEO)

• one use applied for by Idexx Montpellier SAS (4 January 2033); and
• one use applied for by Idexx B.V. (4 January 2033).